Evelo Biosciences shares are trading lower after TD Cowen downgraded the stock from Outperform to Market Perform.
Portfolio Pulse from Benzinga Newsdesk
Evelo Biosciences' stock has been downgraded from Outperform to Market Perform by TD Cowen, causing a decrease in the share price.
October 18, 2023 | 5:14 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Evelo Biosciences' stock was downgraded by TD Cowen, which has led to a decrease in its share price.
The downgrade by TD Cowen from Outperform to Market Perform indicates a less optimistic outlook for the company's stock. This can lead to selling pressure among investors, causing a decrease in the share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100